2-Chlorothiazole-4-Carboxylicacid Ethyl Ester

In the manufacture of parenteral cephalosporin antibiotics, 2-chlorothiazole-4-carboxylic acid ethyl ester serves as the strategic electrophilic partner for constructing the (2-aminothiazol-4-yl)-2-methoxyiminoacetyl side chain found in third- and fourth-generation agents. Production campaigns conducted in multipurpose API facilities under ICH Q7 and 21 CFR Part 211 demand rigorous control of residual chlorine and genotoxic impurities; batch records routinely reference 21 CFR 211.65 regarding equipment surface finish and 211.84 for incoming component identity testing. The ammonolysis step, which converts the 2-chloro substituent to the free amino group, is typically carried out by charging the ester and aqueous ammonia at a molar ratio of 1:8 to 1:12 (ester:NH₃) into a Hastelloy C-276-lined pressure vessel pressurised to 0.4–0.6 MPa and heated to 105–115 °C for 6–10 h. Pseudo-first-order kinetic data generated from in-line FTIR monitoring of analogous 2-halothiazole systems indicate an activation energy in the range of 48–55 kJ·mol⁻¹; prolonged hold times at the upper temperature boundary increase the population of the des-chloro hydrolysis by-product beyond 2.0 area%, requiring a narrow processing window. Downstream, the resulting 2-aminothiazole-4-carboxylic acid ethyl ester is condensed with 2-methoxyiminoacetoacetic acid tert-butyl ester under Dean–Stark azeotropic water removal, followed by ester hydrolysis and salt formation. Observed batch-to-batch variability in the active methylene coupling step has been traced to residual moisture in the reactor headspace exceeding 0.05% Karl Fischer titre, which decomposes the iminoether intermediate; production-scale batches therefore employ a nitrogen-purge protocol maintaining headspace dew point below –40 °C. Finished dosage forms include sterile lyophilised powders of ceftazidime pentahydrate and cefepime hydrochloride intended for intravenous infusion, delivered in 1 g and 2 g single-dose vials compliant with USP <797> compounding standards.

Corrosion coupons retrieved from 316L stainless steel autoclaves after 12 consecutive ammonia campaigns show intergranular attack at weld seams; migrating nickel and chromium ions necessitate a chelating resin guard column before the acyl chloride formation step. The corresponding continuous-flow process, executed in a silicon carbide (SiC) microreactor with a channel diameter of 1.0 mm, suppresses metal leaching entirely but imposes a maximum acceptable particle size of 5 µm for any precipitated ammonium chloride to prevent channel blockage.

Solvent-Free Condensation of the Ester with 2,6-Dibromo-4-trifluoromethoxy-aniline

For the synthesis of thiazole carboxanilide fungicides targeting succinate dehydrogenase (SDHI), 2-chlorothiazole-4-carboxylic acid ethyl ester is reacted with substituted anilines in a melt-phase amidation that eliminates volatile organic solvents from the manufacturing train. Process validation filings submitted under FAO Specification 589/TC and the corresponding CIPAC Handbook K methods mandate identification of all by-products exceeding 0.1% by LC-MS. The charging protocol feeds the ester and 2,6-dibromo-4-trifluoromethoxy-aniline at a molar ratio of 1:1.05—the slight excess of nucleophile compensates for sublimation losses at reaction temperature—into a zirconium paddle horizontal kneader preheated to 90 °C. Phosphorus oxychloride is metered in as the condensation agent at a rate maintaining an internal temperature not exceeding 105 °C; exotherm excursions beyond 112 °C are specifically avoided because differential scanning calorimetry registers an exothermic decomposition of the product mixture with an onset at 118 °C and an energy release of 670 J·g⁻¹. The kneader is then evacuated to 80 mbar to strip residual HCl and POCl₃, while the torque signal on the drive motor serves as an indirect measure of melt viscosity, which increases from an initial 0.8 Pa·s to a final plateau of 3.2 Pa·s upon complete conversion. Downstream, the crude melt is quenched into deionised water at 40 °C, granulised through a 500 µm screen, and purified by slurry washing at a pH 8.0 ± 0.2 sodium bicarbonate buffer. The reprecipitated solid is dried under vacuum (≤ 50 °C, 24 h) to a residual water content below 0.3%. Terminal formulations that incorporate the resulting N-(2-chlorothiazole-4-carbonyl) anilide intermediate belong to the broad class of carboxamide fungicides applied as suspension concentrates (SC) or water-dispersible granules (WG) at field rates of 100–250 g a.i.·ha⁻¹ in cereal and oilseed rape protection programmes.

Production-scale runs in a 500 L kneader have documented that iron content in the base phosphorous oxychloride exceeding 15 ppm correlates with a drop in isolated yield of 5–7% due to iron-catalysed dehalogenation of the thiazole ring; a specification limit of <10 ppm Fe is therefore written into the raw material purchase agreement. Additionally, the absence of solvent in the condensation step mandates engineering controls to capture sublimed aniline vapour, typically via a condenser train operating with a coolant inlet temperature of –15 °C.

When the N-(2-chlorothiazole-4-carbonyl) anilide scaffold is applied as a copper corrosion inhibitor in oilfield acidising operations, the ethyl ester moiety is first hydrolysed to the carboxylic acid or directly amidated with long-chain alkylamines to afford water-dispersible film-forming molecules. Qualification testing follows the general framework of NACE TM0169 and ASTM G31-72, with weight-loss coupons fabricated from API 5L X52 carbon steel. Static immersion tests conducted in deaerated 15 wt% HCl at 60 °C for a duration of 6 h demonstrate that the concentration of the prepared amide inhibitor required to achieve a corrosion rate below 5 mm·year⁻¹ lies between 200 ppm and 500 ppm (v/v). Electrochemical impedance spectroscopy performed in a three-electrode glass cell with a rotating cylindrical electrode at 1000 rpm reveals that the inhibitor behaves as a mixed-type interface blocker, with the polarisation resistance increasing from 28 Ω·cm² (blank acid) to 840–1100 Ω·cm² at the effective dose. Field blending instructions specify that the inhibitor intermediate, supplied as a 70% active concentrate in ethylene glycol monobutyl ether, is co-injected with the stimulation acid via a positive displacement pump at a pre-flush stage lasting 45–60 minutes; this procedure aligns with the operational guidelines given in API RP 54 for matrix acidising of sandstone reservoirs. The final formulated product is stored in high-density polyethylene totes under a nitrogen pad to prevent oxidative dimerisation of the thiazole ring that manifests as a colour shift from pale amber to dark brown accompanied by a loss of inhibition efficiency of approximately 15% after 72 h of air exposure.

Can the Ester Survive the Curtius Rearrangement for Thiazole-4-amino Acid Synthesis?

Incorporation of a 2-aminothiazole-4-carbonyl moiety as a constrained amino acid isostere into peptidomimetic backbones often routes through 2-(Boc-amino)thiazole-4-carboxylic acid, a building block whose preparation begins with this same ethyl ester. The ester is first converted to the corresponding hydrazide by treatment with hydrazine hydrate (1.5 eq.) in ethanol at reflux for 4 h; after solvent swap into 1,2-dimethoxyethane and cooling to –10 °C, a stoichiometric quantity of nitrosyl chloride (generated in situ from NaNO₂ and HCl) generates the acyl azide. Safety calorimetry (ARC) on the isolated azide intermediate records an onset temperature for decomposition of 67 °C with a maximum self-heat rate of 220 °C·min⁻¹, classifying the species as a class 3 explosive according to UN Test Series 3(c) criteria and imposing a strict batch size limit of 2 kg in a dedicated bunker cell. The azide solution is slowly warmed to 80 °C in the presence of tert-butanol (10 eq.), effecting the Curtius rearrangement to the isocyanate and trapping it in situ as the Boc-protected amine. The isolated yield after precipitation with cold heptane typically falls in the range of 68–75%, and the purity is validated against a reference standard characterised by USP <621> HPLC with a C18 column using a phosphate buffer–acetonitrile gradient. Subsequent deblocking with trifluoroacetic acid and Fmoc protection (Fmoc-OSu, 1.2 eq. in aqueous dioxane) furnishes the ready-to-couple monomer for solid-phase peptide synthesis on a Rink amide AM resin. Finished peptide constructs—typically cyclic tetrapeptides or bicyclic pentapeptides designed for protease inhibition or protein–protein interaction targets—are purified by preparative reverse-phase HPLC to a single conformational isomer and characterised by high-resolution mass spectrometry with an acceptance threshold of <5 ppm mass accuracy. The entire synthesis train, from the intact ethyl ester to the finished protected amino acid, is subject to impurity fate and purge studies described in ICH Q3A and ICH M7 Addendum, with specific attention paid to the removal of the des-chloro impurity and residual hydrazine quantified via a validated ion chromatography method achieving a limit of quantitation of 0.05 µg·mL⁻¹.

Direct Arylation at C-5 is Achieved Without Protective Group Manipulation

The 2-chlorothiazole-4-carboxylic acid ethyl ester substructure presents a differentiated electronic landscape that enables chemodivergent palladium-catalysed cross-coupling. When the goal is the rapid construction of compound arrays for early-stage fragment screening, direct C-5 arylation using Pd(PPh₃)₄ (2 mol%) and potassium carbonate (2.0 eq.) in dimethylacetamide at 110 °C for 16 h furnishes 5-aryl-2-chloro-thiazole-4-carboxylate derivatives without cleaving the ethyl ester or displacing the 2-chloro handle. A typical reaction setup employs an array of 96-well Schlenk-style reactors under an atmosphere of argon (p(O₂) < 5 ppm), heated in a solid-state thermocycler block calibrated to ±0.3 °C. Aryl boronic acids (1.2 eq.) bearing electron-withdrawing substituents give isolated yields in the 60–85% range after automated silica gel chromatography, whereas ortho-substituted and strongly electron-donating partners exhibit conversion plateaus near 40% due to competing protodeboronation; addition of SPhos (4 mol%) as a supporting ligand partially mitigates this limitation for the more challenging substrates. All parallel synthesis steps are conducted under a quality system consistent with ISO 9001:2015, and the analytical release of library members adopts the chromatographic system suitability criteria of USP <621>, requiring a tailing factor below 2.0 and a signal-to-noise ratio ≥ 10 for the quantitation limit. The resulting 5-aryl chlorothiazole esters feed into downstream Suzuki or Buchwald–Hartwig couplings at the C-2 position with a reactivity sequence that illustrates the kinetic preference for oxidative addition at the C-Cl bond over subsequent C-5 functionalisation. Such orthogonal reactivity is exploited to generate 250–500 mg quantities of drug-like N,C-bifunctionalised thiazoles per well, which are directly submitted for biochemical high-throughput screening against kinase and protease panels without further purification beyond a rapid solid-phase extraction step.

The use of a single-charge carbonylative coupling variant (CO balloon, 1 atm, Pd(dppf)Cl₂, 3 mol%) allows insertion of carbon monoxide at the C-5 position to give the mixed diester in 51% isolated yield, expanding the accessible chemical space to thiazole-4,5-dicarboxylate scaffolds that mimic pyridine dicarboxylate motifs found in glutamate receptor ligands. Published literature on this specific transformation remains sparse; the reported yields reflect carefully optimised small-scale preparations and scale-up beyond 10 mmol has not been independently verified in pilot-plant campaigns, so adaptation to production-scale chemistry would require re-engineering of gas-liquid mass transfer using a thin-film rotating disc contactor.